MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 140 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,074,990 | -20.7% | 1,807,499 | -1.5% | 0.00% | 0.0% |
| Q2 2023 | $22,802,748 | -11.6% | 1,834,493 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $25,784,691 | -50.2% | 1,840,468 | -49.1% | 0.00% | -50.0% |
| Q4 2022 | $51,750,370 | +15.5% | 3,616,378 | +106.1% | 0.00% | -33.3% |
| Q3 2022 | $44,805,000 | -9.8% | 1,754,976 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $49,686,000 | -22.2% | 1,748,888 | -3.4% | 0.00% | 0.0% |
| Q1 2022 | $63,850,000 | -5.3% | 1,810,317 | +12.5% | 0.00% | 0.0% |
| Q4 2021 | $67,418,000 | -1.0% | 1,609,033 | +16.0% | 0.00% | -25.0% |
| Q3 2021 | $68,068,000 | +33.7% | 1,386,875 | +13.6% | 0.00% | +33.3% |
| Q2 2021 | $50,927,000 | +120.3% | 1,220,384 | +88.2% | 0.00% | +200.0% |
| Q1 2021 | $23,114,000 | – | 648,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |